Integrin alpha2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model. Eissa IR, Wang Y, Tanabe KK. Breast Cancer Res Treat 2026;219:16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eissa IR, Wang Y, Tanabe KK. Integrin alpha2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model. Breast Cancer Res Treat 2026;219:16.
PMID: 42747603